Medication info

Alniz Tablet

Prescription medicationTabletOralExpired
Ingredient · strength
Ranitidine Hydrochloride›84mg / 1 tabletSucralfate Hydrate›300mg / 1 tabletTripotassium Bismuth Dicitrate›100mg / 1 tablet
Manufacturer / importer
Hyun's Meditech Co., Ltd.
Appearance
Green round film-coated tablets
Packaging
30 tablets/bottle, 500 tablets/bottle
Approval status
Expired

MFDS item code 201508486 · Approved 2015.12.29

This product's status changed to Expired on 2025.12.29. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Treatment of acid-related disorders (e.g., ulcers, gastritis, and reflux esophagitis); prevention of Mendelson syndrome
Who takes it
Adults · Children
Adult dose
Usually, take 2 tablets per dose twice daily, in the morning and at bedtime, regardless of meals. Gastric and duodenal ulcers: Administer 2 tablets per dose twice daily or 4 tablets per dose once daily at bedtime. In particular, a higher healing rate may be achieved in patients with duodenal ulcers by administering 4 tablets per dose twice daily, in the morning and at bedtime. The dosage is the same when this medicine is used concomitantly to treat ulcers caused by nonsteroidal anti-inflammatory drugs (NSAIDs) or to prevent the development of gastric or duodenal ulcers during long-term NSAID treatment. These conditions generally heal within 4 weeks when caused by NSAID treatment and within 8 weeks in other cases; however, healing may occasionally take longer in some patients. For patients with recurrent ulcers who responded well to short-term treatment with this medicine, administer 2 tablets per dose once daily at bedtime as maintenance therapy. Reflux esophagitis: Administer 2 tablets per dose twice daily for 8 weeks or 4 tablets per dose once daily at bedtime. The dose may be increased to 4 tablets per dose four times daily in patients with severe reflux esophagitis. Zollinger-Ellison syndrome: Initiate treatment with an initial dose of 2 tablets per dose three times daily, and increase the dose as needed. For severe disease, up to 6 g of ranitidine per day may be administered as directed by a physician. Upper gastrointestinal bleeding associated with acute peptic ulcers, acute stress ulcers, and acute gastric mucosal lesions: Once oral administration becomes possible, switch from injection to oral administration and administer 2 tablets per dose twice daily. Administer 2 tablets as a single dose 2 hours before induction of anesthesia. In this case, it is preferable to also administer 2 tablets as a single dose on the night before surgery. For patients with severe renal impairment and a creatinine clearance of 50ml/min or less, take 2 tablets per dose once daily at bedtime. This may vary depending on the patient's condition. Since hemodialysis reduces the plasma concentration of the medicine, readjust the dosing schedule immediately after hemodialysis.
Child dose
For children aged 8-18 years, 2 tablets per dose (2mg/kg as ranitidine) may be taken up to 2 times daily.

Ingredients

Manufacturer
Hyun's Meditech Co., Ltd.

Efficacy & effects

Treatment of acid-related disorders (e.g., ulcers, gastritis, and reflux esophagitis); prevention of Mendelson syndrome

  • Gastric ulcer
  • gastritis
  • duodenal ulcer
  • Zollinger-Ellison syndrome
  • gastroesophageal reflux disease
  • Mendelson syndrome
  • postoperative ulcer
  • gastric and duodenal ulcers due to non-steroidal anti-inflammatory drugs (NSAIDs)
View approved original text

This medicine is used for gastrointestinal diseases such as gastric ulcer, gastritis, and duodenal ulcer. It is also effective in treating Zollinger-Ellison syndrome and gastroesophageal reflux disease. It can be administered to prevent ulcers after surgery or to prevent Mendelson syndrome before anesthesia. It is used for the treatment of gastric and duodenal ulcers caused by non-steroidal anti-inflammatory drugs (NSAIDs). In summary, this medicine is used to prevent and treat various gastrointestinal diseases and their related complications.

How to take

Adult dose

Usually, take 2 tablets per dose twice daily, in the morning and at bedtime, regardless of meals. Gastric and duodenal ulcers: Administer 2 tablets per dose twice daily or 4 tablets per dose once daily at bedtime. In particular, a higher healing rate may be achieved in patients with duodenal ulcers by administering 4 tablets per dose twice daily, in the morning and at bedtime. The dosage is the same when this medicine is used concomitantly to treat ulcers caused by nonsteroidal anti-inflammatory drugs (NSAIDs) or to prevent the development of gastric or duodenal ulcers during long-term NSAID treatment. These conditions generally heal within 4 weeks when caused by NSAID treatment and within 8 weeks in other cases; however, healing may occasionally take longer in some patients. For patients with recurrent ulcers who responded well to short-term treatment with this medicine, administer 2 tablets per dose once daily at bedtime as maintenance therapy. Reflux esophagitis: Administer 2 tablets per dose twice daily for 8 weeks or 4 tablets per dose once daily at bedtime. The dose may be increased to 4 tablets per dose four times daily in patients with severe reflux esophagitis. Zollinger-Ellison syndrome: Initiate treatment with an initial dose of 2 tablets per dose three times daily, and increase the dose as needed. For severe disease, up to 6 g of ranitidine per day may be administered as directed by a physician. Upper gastrointestinal bleeding associated with acute peptic ulcers, acute stress ulcers, and acute gastric mucosal lesions: Once oral administration becomes possible, switch from injection to oral administration and administer 2 tablets per dose twice daily. Administer 2 tablets as a single dose 2 hours before induction of anesthesia. In this case, it is preferable to also administer 2 tablets as a single dose on the night before surgery. For patients with severe renal impairment and a creatinine clearance of 50ml/min or less, take 2 tablets per dose once daily at bedtime. This may vary depending on the patient's condition. Since hemodialysis reduces the plasma concentration of the medicine, readjust the dosing schedule immediately after hemodialysis.

Child dose

For children aged 8-18 years, 2 tablets per dose (2mg/kg as ranitidine) may be taken up to 2 times daily.

Precautions

This medicine should not be used in patients undergoing dialysis treatment. Patients allergic to ranitidine hydrochloride should not take this medicine. For patients with impaired renal function, the drug may remain in the body for a long time, so the dosage should be reduced or the dosing interval should be increased for careful use. Caution is also required for patients with liver dysfunction when using this medicine. Patients with a history of drug allergies and the elderly should be careful when taking this medicine. Rarely, severe allergic reactions such as shock may occur while taking this medicine; if symptoms appear, immediately discontinue the medication and seek medical attention. If allergic symptoms such as rash, hives, swelling of the face or neck, fever, shortness of breath, or low blood pressure occur, stop taking the medicine and consult a doctor. A blood test may show a decrease in white blood cells or platelets, and liver function test values may temporarily rise. Irregular heartbeat or symptoms of fast or slow heart rate have been reported rarely. Digestive symptoms may include nausea, vomiting, constipation, diarrhea, abdominal bloating, and abdominal pain, and stool color may change, but this does not require special treatment. Nervous system symptoms such as dizziness, drowsiness, confusion, seizures, anxiety, depression, hallucinations, insomnia, and headaches may appear rarely. Gynecomastia or sexual dysfunction has been reported, but the direct relation to this medicine is not clear. Joint pain, rash including mild polymorphic erythema, hair loss, and itching may occur, but these symptoms are mostly temporary. It is advisable not to use this medicine for a long time, and patients with a history of kidney disease should consult a doctor or pharmacist before taking it. Monitor the treatment's progress and use the minimum effective dose; if there is no effect, it should be changed to another medication. Women who are pregnant or may become pregnant should only take this medicine when the benefits of treatment outweigh the risks, as its safety is not guaranteed. This medicine may be transmitted through breast milk, so breastfeeding should be avoided during treatment. Safety in children has not been sufficiently established, so it should be used cautiously in children. Some urine tests may yield false-positive results, so it is advisable to use specific test methods for accurate testing. In case of overdose, emergency measures such as vomiting or gastric lavage may be necessary, and if needed, the drug can be removed through hemodialysis. This medicine can mask symptoms of gastric cancer, so it should only be used after confirming whether it is malignant. Long-term use may affect the eyes, so it is advisable to have regular ophthalmic examinations while using it.

Side effects

  • Shock
  • skin rash
  • urticaria
  • angioedema
  • fever
  • bronchospasm
  • hypotension
  • leukopenia
  • thrombocytopenia
  • elevated serum creatinine
Show 44 more
  • elevated serum transaminases
  • agranulocytosis
  • pancytopenia
  • bone marrow failure
  • aplastic anemia
  • eosinophilia
  • elevated S-GOT
  • elevated S-GPT
  • elevated r-GPT
  • elevated ALP
  • jaundice hepatitis
  • non-jaundice hepatitis
  • tachycardia
  • bradycardia
  • heart block
  • premature ventricular contractions
  • nausea
  • vomiting
  • constipation
  • diarrhea
  • abdominal distension
  • abdominal pain
  • loss of appetite
  • hallucination
  • drowsiness
  • confusion
  • convulsions
  • agitation
  • depression
  • hallucinations
  • insomnia
  • headache
  • heaviness in the head
  • body perception disorder
  • blurred vision
  • gynecomastia
  • impotence
  • sexual dysfunction
  • arthralgia
  • rash
  • hair loss
  • skin pruritus
  • stomatitis
  • blackening of the tongue

Not everyone experiences these, and they can vary from person to person.

Storage

This medicine should be stored in a tightly closed container to prevent air or moisture from entering. It is important to maintain a storage temperature between 1 and 30 degrees Celsius.

Appearance and packaging

Appearance

Green round film-coated tablets

Package unit

30 tablets/bottle, 500 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.